Security key
68403P203
ORAMED PHARMACEUTICALS INC. - Common Stock (ORMP)
CUSIP: 68403P203
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 5,157,802
- Total 13F value
- $11,912,739
- Share change
- +2,851,720
- Put/Call ratio
- 11%
- SEC-reported price per share
- $2.31
- Number of holders
- 56
- Value change
- +$6,481,828
- Number of buys
- 24
- Number of sells
- 19
- Shares outstanding
- 40,467,431
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
56
Top holders
10
ORMP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
ORAMED PHARMACEUTICALS INC. SEC filings
ORAMED PHARMACEUTICALS INC. company facts
ORAMED PHARMACEUTICALS INC. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 68403P203
Recent filing periods:
Ownership snapshot
Top reported holders of ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BML Capital Management, LLC
Disclosed value leader
BML Capital Management, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 1.9%
Showing 1-6 of 15 holder rows.
Quick read
BML Capital Management, LLC leads the comparable SEC ownership view at 1.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BML Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
BML Capital Management, LLC
1.9%
Rathbones Group PLC
0.72%
TWO SIGMA ADVISERS, LP
0.41%
GOLDMAN SACHS GROUP INC
0.38%
GSA CAPITAL PARTNERS LLP
0.22%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BML Capital Management, LLC |
13F
Company
|
1.9%
|
$2,039,172
781,292 shares
|
— | 30 Sep 2023 |
| Rathbones Group PLC |
13F
Company
|
0.72%
|
$756,386
289,803 shares
|
— | 30 Sep 2023 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
0.41%
|
$432,216
165,600 shares
|
— | 30 Sep 2023 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.38%
|
$400,943
153,618 shares
|
— | 30 Sep 2023 |
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
0.22%
|
$232,000
88,923 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
0.22%
|
$231,763
88,798 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
56
Shares
5,157,802
Rows available
56
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
55
Q4 2023 holders
56
Holder diff
1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend